Hirota H - Search Results

1

Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy.

Lin YW, Kubota M, Wakazono Y, Hirota H, Okuda A, Bessho R, Usami I, Kataoka A, Yamanaka C, Akiyama Y, Furusho K. Lin YW, et al. Among authors: hirota h. Mutat Res. 1996 Jan 2;362(1):97-103. doi: 10.1016/0921-8777(95)00039-9. Mutat Res. 1996. PMID: 8538654

2

Different effect of thymidine kinase loss on TTP pools; comparison among human leukemia cell lines.

Wakazono Y, Kubota M, Sano H, Matsubara K, Hirota H, Kuwakado K, Adachi S. Wakazono Y, et al. Among authors: hirota h. Mutat Res. 1994 Jan 16;304(2):295-300. doi: 10.1016/0027-5107(94)90222-4. Mutat Res. 1994. PMID: 7506373

3

Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation.

Hirota H, Kubota M, Adachi S, Okuda A, Lin YW, Bessho R, Wakazono Y, Matsubara K, Kuwakado K, Akiyama Y, et al. Hirota H, et al. Mutat Res. 1994 Sep;315(2):95-103. doi: 10.1016/0921-8777(94)90010-8. Mutat Res. 1994. PMID: 7521002

4

Somatic cell mutation frequency at the HPRT, T-cell antigen receptor and glycophorin A loci in Cockayne syndrome.

Lin YW, Kubota M, Hirota H, Furusho K, Tomiwa K, Ochi J, Kasahara Y, Sasaki H, Ohta S. Lin YW, et al. Among authors: hirota h. Mutat Res. 1995 Jul;337(1):49-55. doi: 10.1016/0921-8777(95)00014-b. Mutat Res. 1995. PMID: 7596357

5

Analysis of hprt gene mutation following anti-cancer treatment in pediatric patients with acute leukemia.

Hirota H, Kubota M, Hashimoto H, Adachi S, Matsubara K, Kuwakado K, Akiyama Y, Tsutsui T, Mikawa H. Hirota H, et al. Mutat Res. 1993 Oct;319(2):113-20. doi: 10.1016/0165-1218(93)90069-p. Mutat Res. 1993. PMID: 7692286

6

Biomarkers in long survivors of pediatric acute lymphoblastic leukemia patients: late effects of cancer chemotherapy.

Koishi S, Kubota M, Sawada M, Hirota H, Hashimoto H, Lin YW, Watanabe K, Usami I, Akiyama Y, Furusho K. Koishi S, et al. Among authors: hirota h. Mutat Res. 1998 Dec 3;422(2):213-22. doi: 10.1016/s0027-5107(98)00199-7. Mutat Res. 1998. PMID: 9838123

7

Cancer chemotherapy and somatic cell mutation.

Kubota M, Lin YW, Hamahata K, Sawada M, Koishi S, Hirota H, Wakazono Y. Kubota M, et al. Among authors: hirota h. Mutat Res. 2000 Oct 31;470(2):93-102. doi: 10.1016/s1383-5742(00)00043-0. Mutat Res. 2000. PMID: 11027962 Review.

8

In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro.

Adachi S, Kubota M, Lin YW, Okuda A, Matsubara K, Wakazono Y, Hirota H, Kuwakado K, Akiyama Y. Adachi S, et al. Among authors: hirota h. Eur J Haematol. 1994 Sep;53(3):129-34. doi: 10.1111/j.1600-0609.1994.tb00660.x. Eur J Haematol. 1994. PMID: 7523181 Clinical Trial.

9

Variable susceptibility to apoptosis induced by calcium ionophore in hybridomas between HL-60 promyelocytic and CEM T-lymphoblastic leukemia cell lines: relationship to constitutive Mg(2+)-dependent endonuclease.

Matsubara K, Kubota M, Kuwakado K, Hirota H, Wakazono Y, Okuda A, Bessho R, Lin YW, Adachi S, Akiyama Y. Matsubara K, et al. Among authors: hirota h. Exp Cell Res. 1994 Aug;213(2):412-7. doi: 10.1006/excr.1994.1217. Exp Cell Res. 1994. PMID: 8050497

10

Mechanism of enhancement of neutrophil survival by granulocyte colony-stimulating factor and adenine.

Adachi S, Kubota M, Wakazono Y, Hirota H, Matsubara K, Kuwakado K, Akiyama Y, Mikawa H. Adachi S, et al. Among authors: hirota h. Exp Hematol. 1993 Aug;21(9):1213-8. Exp Hematol. 1993. PMID: 7687217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters